Elsevier

Neurobiology of Disease

Volume 5, Issue 6, December 1998, Pages 502-533
Neurobiology of Disease

Regular Article
Cannabinoid Transmission and Reward-Related Events

https://doi.org/10.1006/nbdi.1998.0219Get rights and content

Abstract

The reward/reinforcement circuitry of the mammalian brain consists of synaptically interconnected neurons associated with the medial forebrain bundle, linking the ventral tegmental area, nucleus accumbens, and ventral pallidum. Electrical stimulation of this circuit supports intense self-stimulation in animals and, in humans, produces intense pleasure or euphoria. This circuit is strongly implicated in the neural substrates of drug addiction and in such addiction-related phenomena as withdrawal dysphoria and craving. This circuit is also implicated in the pleasures produced by natural rewards (e.g., food, sex). Cannabinoids are euphorigenic in humans and have addictive liability in vulnerable persons, but were long considered “anomalous” drugs of abuse, lacking pharmacological interaction with these brain reward substrates. It is now clear, however, that cannabinoids activate these brain substrates and influence reward-related behaviors. From these actions, presumably, derive both the abuse potential of cannabinoids and the possible clinical efficacy in dysphoric states.

References (315)

  • M. Rinaldi-Carmona et al.

    Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist

    Life Sci.

    (1995)
  • T. Sugiura et al.

    N

    J. Lipid Mediators Cell Signalling

    (1996)
  • R. Mechoulam et al.

    Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

    Biochem. Pharmacol.

    (1995)
  • T. Sugiura et al.

    2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain

    Biochem. Biophys. Res. Commun.

    (1995)
  • S.R. Childers et al.

    Effects of anandamide on cannabinoid receptors in rat brain membranes

    Biochem. Pharmacol.

    (1994)
  • B. Koutek et al.

    Inhibitors of arachidonoyl ethanolamide hydrolysis

    Biol. Chem.

    (1994)
  • F. Desarnaud et al.

    Anandamide amidohydrolase activity in rat brain microsomes: Identification and partial characterization

    J. Biol. Chem.

    (1995)
  • J.N. Crawley et al.

    Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents

    Pharmacol. Biochem. Behav.

    (1993)
  • R. Mechoulam et al.

    Search for endogenous ligands of the cannabinoid receptor

    Biochem. Pharmacol.

    (1994)
  • J. Barg et al.

    Cannabimimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides

    Eur. J. Pharmacol.

    (1995)
  • R.A. Wise

    Action of drugs of abuse on brain reward systems

    Pharmacol. Biochem. Behav.

    (1980)
  • A. Imperato et al.

    Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats

    Eur. J. Pharmacol.

    (1986)
  • E. Carboni et al.

    Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely-moving rats

    Neuroscience

    (1989)
  • M.A. Bozarth et al.

    Intracranial self-administration of morphine into the ventral tegmental area of rats

    Life Sci.

    (1981)
  • N.E. Goeders et al.

    Self-administration of methionine enkephalin into the nucleus accumbens

    Pharmacol. Biochem. Behav.

    (1984)
  • A.G. Phillips et al.

    Reinforcing effects of morphine microinjection into the ventral tegmental area

    Pharmacol. Biochem. Behav.

    (1980)
  • M.A. Bozarth et al.

    Heroin reward is dependent on a dopaminergic substrate

    Life Sci.

    (1981)
  • R.A. Wise

    Neurobiology of addiction

    Curr. Opin. Neurobiol.

    (1996)
  • E.J. Nestler

    Molecular mechanisms of drug addiction in the mesolimbic dopamine pathway

    Semin. Neurosci.

    (1993)
  • E.L. Gardner et al.

    Drug craving and positive/negative hedonic brain substrates activated by addicting drugs

    Semin. Neurosci.

    (1993)
  • G. Di Chiara

    The role of dopamine in drug abuse viewed from the perspective of its role in motivation

    Drug Alcohol Depend.

    (1995)
  • P. Shizgal

    Neural basis of utility estimation

    Curr. Opin. Neurobiol.

    (1997)
  • E.L. Gardner et al.

    Overview of chemical sampling techniques

    J. Neurosci. Methods

    (1993)
  • E.L. Gardner et al.

    Marijuana's interaction with brain reward systems: Update 1991

    Pharmacol. Biochem. Behav.

    (1991)
  • M. Lepore et al.

    Genetic differences in Δ9

    Life Sci. (Pharmacol. Lett.)

    (1996)
  • F.R. George et al.

    Genetic approaches to the analysis of addiction processes

    Trends Pharmacol. Sci.

    (1989)
  • Marijuana/Cannabinoids: Neurobiology and Neurophysiology

    (1992)
  • W.A. Devane et al.

    Determination and characterization of a cannabinoid receptor in rat brain

    Mol. Pharmacol.

    (1988)
  • M. Johnson et al.

    Structural studies leading to the discovery of a cannabinoid binding site

    Natl. Inst. Drug Abuse Res. Monogr. Ser.

    (1988)
  • A.C. Howlett et al.

    Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model

    Mol. Pharmacol.

    (1988)
  • M. Bidaut-Russell et al.

    Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain

    J. Neurochem.

    (1990)
  • L.A. Matsuda et al.

    Structure of a cannabinoid receptor and functional expression of the cloned cDNA

    Nature

    (1990)
  • S. Munro et al.

    Molecular characterization of a peripheral receptor for cannabinoids

    Nature

    (1993)
  • M. Herkenham et al.

    Cannabinoid receptor localization in brain

    Proc. Natl. Acad. Sci. USA

    (1990)
  • M. Herkenham et al.

    Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study

    J. Neurosci.

    (1991)
  • M. Rinaldi-Carmona et al.

    Characterization of two cloned human CB1 cannabinoid receptor isoforms

    J. Pharmacol. Exp. Ther.

    (1996)
  • A. Makriyannis

    Probes for the cannabinoid sites of action

    Natl. Inst. Drug Abuse Res. Monogr. Ser.

    (1993)
  • L.S. Melvin et al.

    Structure–activity relationships for receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogs

    Mol. Pharmacol.

    (1993)
  • L.S. Melvin et al.

    Structure–activity relationships defining the ACD-tricyclic cannabinoids: Cannabinoid receptor binding and analgesic activity

    Drug Design Disc.

    (1995)
  • Cited by (0)

    Murphy, L.Bartke, A.

    1

    To whom correspondence and reprint requests should be addressed. Fax: (718) 430-8772. E-mail:[email protected].

    View full text